Apex Bioscience, Inc.
Records under this name other than patents Apex Bioscience, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,747,132 | Methods for the synthesis of a modified hemoglobin solution Formerly held Term ended Term ended Sep 24, 2021 · From the USPTO record | Term ended | Term ended Sep 24, 2021 | From the USPTO record |
| US 6,020,308 | Methods for improving therapeutic effectiveness of treatment of vascularization disorders Term ended Term ended Jul 31, 2018 · From the USPTO record | Term ended | Term ended Jul 31, 2018 | From the USPTO record |
| US 7,038,016 | Methods for purification of an activated PEG solution and for the synthesis of a modified hemoglobin solution Formerly held Lapsed on the fee record Ended May 2, 2018 · From the USPTO record | Lapsed on the fee record | Ended May 2, 2018 | From the USPTO record |
| US 6,172,039 | Expression of recombinant hemoglobin and hemoglobin variants in yeast Lapsed on the fee record Ended Jan 9, 2013 · From the USPTO record | Lapsed on the fee record | Ended Jan 9, 2013 | From the USPTO record |
| US 6,103,690 | Prevention or inhibition of pathogenic syndromes caused by nitric oxide overproduction using iron-containing hemoprotein Lapsed on the fee record Ended Aug 15, 2012 · From the USPTO record | Lapsed on the fee record | Ended Aug 15, 2012 | From the USPTO record |
| US 6,350,729 | Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein Term ended Ended no later than Feb 19, 2012 · From the USPTO record | Term ended | Ended no later than Feb 19, 2012 | From the USPTO record |
| US 5,296,466 | Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein Term ended Term ended no later than Mar 22, 2014 · Low confidence | Term ended | Term ended no later than Mar 22, 2014 | Low confidence |
| US 5,480,866 | Hemoproteins for inhibition of nitric oxide-mediated hypotension and septic shock Formerly held Term ended Term ended no later than Jan 2, 2016 · Low confidence | Term ended | Term ended no later than Jan 2, 2016 | Low confidence |
| US 5,554,638 | Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders Term ended Term ended no later than Sep 10, 2016 · Low confidence | Term ended | Term ended no later than Sep 10, 2016 | Low confidence |
| US 5,612,310 | Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders Formerly held Term ended Term ended no later than Mar 18, 2017 · Low confidence | Term ended | Term ended no later than Mar 18, 2017 | Low confidence |